HomeRVV • CNSX
add
Revive Therapeutics Ltd
Previous close
$0.010
Day range
$0.010 - $0.015
Year range
$0.0050 - $0.040
Market cap
4.19M CAD
Avg Volume
282.27K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 233.98K | -34.26% |
Net income | -2.59M | -116.80% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -233.90K | 34.26% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 773.07K | -62.96% |
Total assets | 10.64M | -25.37% |
Total liabilities | 3.40M | -5.42% |
Total equity | 7.23M | — |
Shares outstanding | 418.56M | — |
Price to book | 0.50 | — |
Return on assets | -4.92% | — |
Return on capital | -6.83% | — |
Cash Flow
Net change in cash
| (CAD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -2.59M | -116.80% |
Cash from operations | -276.33K | 51.36% |
Cash from investing | 40.00K | — |
Cash from financing | -40.00K | — |
Net change in cash | -276.33K | 51.36% |
Free cash flow | -202.23K | 57.39% |
About
Founded
2012
Headquarters
Website
Employees
2
